<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Sulfonylureas; Sulphonylureas see Sulfonylureas; Glibenclamide; Gliclazide; Tolbutamide" /><meta name="IX" content="Sulfonylureas; Glibenclamide; Gliclazide; Tolbutamide" /><meta name="IXN" content="Sulphonylureas see Sulfonylureas" /><title>6.1.2.1 Sulfonylureas: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP4129-sulfonylureas.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP4129-sulfonylureas.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP4129-sulfonylureas.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4031-endocrine-system.htm">6 Endocrine system</a> &gt; <a href="PHP4032-drugs-used-in-diabetes.htm">6.1 Drugs used in diabetes</a> &gt; <a href="PHP4127-antidiabetic-drugs.htm">6.1.2 Antidiabetic drugs</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP4127-antidiabetic-drugs.htm" title="Previous: 6.1.2 Antidiabetic drugs">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP4140-glibenclamide.htm" title="Next: GLIBENCLAMIDE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a384058.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glyburide</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Hormones and Synthetic Substitutes 68:00 &gt; Antidiabetic Agents 68:20 &gt; Sulfonylureas 68:20.20</p></div></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382481.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Hormones and Synthetic Substitutes 68:00 &gt; Antidiabetic Agents 68:20 &gt; Sulfonylureas 68:20.20</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7217-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Glibenclamide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: G &gt; Interactions of Glibenclamide</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7220-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Gliclazide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: G &gt; Interactions of Gliclazide</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7234-t.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Tolbutamide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: T &gt; Interactions of Tolbutamide</p></div></li></ul><ul><li><h3>British National Formulary (9)</h3></li><li><a href="PHP4140-glibenclamide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">GLIBENCLAMIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs &gt; 6.1.2.1 Sulfonylureas</p></div></li><li><a href="PHP4141-glibenclamide-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glibenclamide</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs &gt; 6.1.2.1 Sulfonylureas &gt; GLIBENCLAMIDE</p></div></li><li><a href="PHP4142-gliclazide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">GLICLAZIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs &gt; 6.1.2.1 Sulfonylureas</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sulfonylureas%22%22sulphonylureas%22%22glibenclamide%22%22gliclazide%22%22tolbutamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (9)</a></li></ul><ul><li><h3>BNF for Children (8)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13248-sulfonylureas.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">6.1.2.1 Sulfonylureas</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13256-glibenclamide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">GLIBENCLAMIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs &gt; 6.1.2.1 Sulfonylureas</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13257-glibenclamide-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glibenclamide</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 6 Endocrine system &gt; 6.1 Drugs used in diabetes &gt; 6.1.2 Antidiabetic drugs &gt; 6.1.2.1 Sulfonylureas &gt; GLIBENCLAMIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sulfonylureas%22%22sulphonylureas%22%22glibenclamide%22%22gliclazide%22%22tolbutamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (8)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0790.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glibenclamide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0792.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gliclazide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1625.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; T</p></div></li></ul><ul><li><h3>Dietary Supplements</h3></li><li><a href="http://www.medicinescomplete.com/mc/diet/2010/c42.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ginkgo biloba</a><div class="breadcrumb"><p><strong>Dietary Supplements</strong> &gt; Monographs &gt; G</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0007s0037.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gliclazide</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0019s0269.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; T</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7200-a3-5-j.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sulfonylureas</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidiabetics &gt; Antidiabetic Drug Groups</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7217-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glibenclamide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidiabetics &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7220-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gliclazide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidiabetics &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sulfonylureas%22%22sulphonylureas%22%22glibenclamide%22%22gliclazide%22%22tolbutamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>The Merck Index (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04439.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gliclazide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; G &gt; GL</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04478.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glyburide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; G &gt; GL</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09507.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; T &gt; TO</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-G32.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glyburide</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-T102.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; T</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (5)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E12E3E0R0D377.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Glibenclamide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E38E3E0R0D1947.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Gliclazide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D987.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Sulfonylureas</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; S</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22sulfonylureas%22%22sulphonylureas%22%22glibenclamide%22%22gliclazide%22%22tolbutamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c171.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Glibenclamide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c172.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gliclazide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; G</p></div></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c365.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Tolbutamide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; T</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1><span>6.1.2.1 </span>Sulfonylureas</h1><?highlighter on?><div id="pC" class="jN"><p>The sulfonylureas act mainly by augmenting insulin secretion and consequently are effective only when some residual pancreatic beta-cell activity is present; during long-term administration they also have an extrapancreatic action. All may cause hypoglycaemia but this is uncommon and usually indicates excessive dosage. Sulfonylurea-induced hypoglycaemia may persist for many hours and must always be treated in hospital.</p> <p>Sulfonylureas are considered for patients who are not overweight, or in whom metformin is contra-indicated or not tolerated. Several sulfonylureas are available and choice is determined by side-effects and the duration of action as well as the patient's age and renal function. <strong>Glibenclamide</strong>, a long-acting sulfonylurea, is associated with a greater risk of hypoglycaemia; for this reason it should be avoided in the elderly, and shorter-acting alternatives, such as <strong>gliclazide</strong> or <strong>tolbutamide</strong>, should be used instead.</p> <p>When the combination of strict diet and sulfonylurea treatment fails, other options include:</p><ul><li><p>combining with metformin (<a title="sub-sub-section: Biguanides" href="PHP4159-biguanides.htm">section 6.1.2.2</a>) (reports of increased hazard with this combination remain unconfirmed);</p> </li><li><p>combining with pioglitazone, but see <a title="sub-sub-section: Other antidiabetics" href="PHP4173-other-antidiabetic-drugs.htm">section 6.1.2.3</a>; </p> </li><li><p>combining with linagliptin, saxagliptin, sitagliptin, or vildagliptin (<a title="sub-sub-section: Other antidiabetics" href="PHP4173-other-antidiabetic-drugs.htm">section 6.1.2.3</a>);</p> </li><li><p>combining with exenatide or liraglutide (<a title="sub-sub-section: Other antidiabetics" href="PHP4173-other-antidiabetic-drugs.htm">section 6.1.2.3</a>);</p> </li><li><p>combining with acarbose (<a title="sub-sub-section: Other antidiabetics" href="PHP4173-other-antidiabetic-drugs.htm">section 6.1.2.3</a>), which may have a small beneficial effect, but flatulence can be a problem;</p> </li><li><p>combining with bedtime isophane insulin (<a title="sub-section: Insulins" href="PHP4035-insulins.htm">section 6.1.1</a>) but weight gain and hypoglycaemia can occur.</p> </li></ul> <p id="PHP4130">The risk of hypoglycaemia associated with sulfonylureas (see notes above) should be discussed with the patient, especially when concomitant glucose-lowering drugs are prescribed.</p> <p>Insulin therapy should be instituted temporarily during intercurrent illness (such as myocardial infarction, coma, infection, and trauma). Sulfonylureas should be omitted on the morning of surgery; insulin is required because of the ensuing hyperglycaemia in these circumstances.</p> <div id="PHP4131"><h2>Cautions</h2><p>Sulfonylureas can encourage weight gain and should be prescribed only if poor control and symptoms persist despite adequate attempts at dieting; metformin (<a title=" Biguanides" href="PHP4159-biguanides.htm">section 6.1.2.2</a>) is considered the drug of choice in obese patients. Caution is needed in the elderly and in patients with G6PD deficiency (<a title="BNF:sub-section: G6PD deficiency" href="PHP5935-g6pd-deficiency.htm">section 9.1.5</a>).</p> </div> <div id="PHP4132"><h2>Contra-indications</h2><p>Sulfonylureas should be avoided where possible in acute porphyria (<a title="BNF:sub-section: Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>). Sulfonylureas are contra-indicated in the presence of ketoacidosis.</p> </div> <div id="PHP4133"><h2>Hepatic impairment</h2><p>Sulfonylureas should be avoided or a reduced dose should be used in severe hepatic impairment, because there is an increased risk of hypoglycaemia. Jaundice may occur.</p></div> <div id="PHP4134"><h2>Renal impairment</h2><p>Sulfonylureas should be used with care in those with mild to moderate renal impairment, because of the hazard of hypoglycaemia; they should be avoided where possible in severe renal impairment. Glipizide should also be avoided if the patient has both renal and hepatic impairment. If necessary, the short-acting drug tolbutamide can be used in renal impairment, as can gliclazide which is principally metabolised in the liver, but careful monitoring of blood-glucose concentration is essential; care is required to use the lowest dose that adequately controls blood glucose.</p></div> <div id="PHP4136"><h2>Pregnancy</h2><p>The use of sulfonylureas in pregnancy should generally be avoided because of the risk of neonatal hypoglycaemia; however, glibenclamide can be used during the second and third trimesters of pregnancy in women with gestational diabetes, see <a title="BNF:target-block: Antidiabetic drugs and pregnancy and breast-feeding" href="PHP4127-antidiabetic-drugs.htm#PHP4128">section 6.1.2</a>.</p></div> <div id="PHP4137"><h2>Breast-feeding</h2><p>The use of sulfonylureas (except glibenclamide [unlicensed use], see <a title="BNF:target-block: Antidiabetic drugs and pregnancy and breast-feeding" href="PHP4127-antidiabetic-drugs.htm#PHP4128">section 6.1.2</a>) in breast-feeding should be avoided because there is a theoretical possibility of hypoglycaemia in the infant.</p></div> <div><h2>Side-effects</h2><p>Side-effects of sulfonylureas are generally mild and infrequent and include gastro-intestinal disturbances such as nausea, vomiting, diarrhoea, and constipation. Hyponatraemia has been reported with glimepiride and glipizide.</p><p>Sulfonylureas can occasionally cause a disturbance in liver function, which may rarely lead to cholestatic jaundice, hepatitis, and hepatic failure. Hypersensitivity reactions can occur, usually in the first 6–8 weeks of therapy. They consist mainly of allergic skin reactions which progress rarely to erythema multiforme and exfoliative dermatitis, fever, and jaundice; photosensitivity has rarely been reported with glipizide. Blood disorders are also rare but may include leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, haemolytic anaemia, and aplastic anaemia.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP4140-glibenclamide"><a href="PHP4140-glibenclamide.htm" title="GLIBENCLAMIDE">GLIBENCLAMIDE</a></li><li id="_PHP4142-gliclazide"><a href="PHP4142-gliclazide.htm" title="GLICLAZIDE">GLICLAZIDE</a></li><li id="_PHP4148-glimepiride"><a href="PHP4148-glimepiride.htm" title="GLIMEPIRIDE">GLIMEPIRIDE</a></li><li id="_PHP4151-glipizide"><a href="PHP4151-glipizide.htm" title="GLIPIZIDE">GLIPIZIDE</a></li><li id="_PHP4156-tolbutamide"><a href="PHP4156-tolbutamide.htm" title="TOLBUTAMIDE">TOLBUTAMIDE</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP4127-antidiabetic-drugs.htm">Previous: 6.1.2 Antidiabetic drugs</a> | <a class="top" href="PHP4129-sulfonylureas.htm#">Top</a> | <a accesskey="]" href="PHP4140-glibenclamide.htm">Next: GLIBENCLAMIDE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>